Quinidine in the treatment of KCNT1-positive epilepsies-Reference-Cited by-同舟云学术

Quinidine in the treatment of KCNT1-positive epilepsies

Published:2015-11-18 Issue:6 Volume:78 Page:995-999
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Mikati Mohamad A¹,Jiang Yong-hui²,Carboni Michael³,Shashi Vandana²,Petrovski Slave⁴,Spillmann Rebecca⁴,Milligan Carol J.⁵,Li Melody⁵,Grefe Annette⁶,McConkie Allyn²,Berkovic Samuel⁷,Scheffer Ingrid⁷,Mullen Saul⁵,Bonner Melanie⁸,Petrou Steven⁷,Goldstein David⁴

Affiliation:

1. Division of Pediatric Neurology, Department of Pediatrics and Department of Neurobiology; Duke University School of Medicine; Durham NC

2. Division of Medical Genetics, Department of Pediatrics; Duke University School of Medicine; Durham NC

3. Division of Cardiology, Department of Pediatrics; Duke University School of Medicine; Durham NC

4. Center for Human Genome Variation; Duke University School of Medicine; Durham NC

5. Florey Institute of Neuroscience and Mental Health; University of Melbourne; Melbourne Victoria Australia

6. Department of Neurology; Wake Forest University; Winston-Salem NC

7. Epilepsy Research Centre, Department of Medicine; University of Melbourne; Melbourne Victoria Australia

8. Department of Psychiatry and Behavioral Sciences; Duke University School of Medicine; Durham NC

Funder

National Health and Medical Research Council

NIH National Institute of Neurological Disorders and Stroke

NIH Centers without Walls “Epi4K”

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference18 articles.

1. Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability;Derry;Epilepsia,2008

2. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy;Hern;Nat Genet,2012

3. Migrating partial seizures in infancy: a malignant disorder with developmental arrest;Coppola;Epilepsia,1995

4. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy;Barcia;Nat Genet,2012

5. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine;Milligan;Ann Neurol,2014

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons;2024-08-28

2. Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons;2024-08-28

3. Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on SST- and PV-expressing cortical GABAergic neurons;2024-08-07

4. WONOEP appraisal: Modeling early onset epilepsies;Epilepsia;2024-07-23

5. New epilepsy therapies in development;Nature Reviews Drug Discovery;2024-07-22